Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product

Lymphoma
13/11/2020

Target Oncol. 2020 Nov 12. doi: 10.1007/s11523-020-00772-4. Online ahead of print.

ABSTRACT

Page 608, 4 Discussion, right column, second paragraph.